Cargando…
Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-induced depression (CID) are limited to those developed for non-cancer related depression. Here, anhedonia-like and coping behaviours were assessed in female BALB/c mice inoculated with 4T1 mammary carcinoma c...
Autores principales: | Nashed, Mina G., Ungard, Robert G., Young, Kimberly, Zacal, Natalie J., Seidlitz, Eric P., Fazzari, Jennifer, Frey, Benicio N., Singh, Gurmit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264609/ https://www.ncbi.nlm.nih.gov/pubmed/28120908 http://dx.doi.org/10.1038/srep41382 |
Ejemplares similares
-
Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain
por: Fazzari, Jennifer, et al.
Publicado: (2015) -
Differences in electrophysiological properties of functionally identified nociceptive sensory neurons in an animal model of cancer-induced bone pain
por: Zhu, Yong Fang, et al.
Publicado: (2016) -
Identification of capsazepine as a novel inhibitor of system x(c)(−) and cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2017) -
Rat model of cancer-induced bone pain: changes in nonnociceptive sensory neurons in vivo
por: Zhu, Yong Fang, et al.
Publicado: (2017) -
Functional effects of TrkA inhibition on system x(C)(−)-mediated glutamate release and cancer-induced bone pain
por: Miladinovic, Tanya, et al.
Publicado: (2018)